We've launched 3 e-learning modules aimed at our screening quality assurance service staff and the professional and clinical advisors who provide specialist expertise.
Nadia is Head of Screening Quality Assurance Development (Clinical) for the Screening Quality Assurance Service (National team)
Nadia Permalloo has worked in screening since 1998. She has worked in screening programmes at local, regional and national levels and is a registered nurse and midwife.
Nadia currently works nationally in quality assurance for the PHE Screening Quality Assurance Service. She cares that women and babies have high quality care and that we should be continually striving to improve what we do by supporting and developing staff delivering screening programmes.
Shared learning in this blog post is specifically aimed at laboratories that provide Down’s, Edwards’ and Patau’s screening.
Report highlights how best performing newborn hearing screening sites ensure early assessment of screen-positive babies in audiology.
We are pleased to publish the first annual data report for the NHS Fetal Anomaly Screening Programme (FASP).
We have published the first annual data report for the NHS Fetal Anomaly Screening Programme (FASP). It covers the period 1 April 2015 to 31 March 2016 and provides feedback on completeness of data submission and performance against the national standards.
We have recently updated and published a one page summary for healthcare professionals explaining which newborn screening tests can be offered at different ages if any of these were initially missed.
If you work in ultrasound or radiology you will be well aware there’s a national shortage of trained staff. Many ultrasound departments rely on agency sonographers.
We use key performance indicator (KPI) data to measure how the NHS screening programmes are performing.
We offer screening for sickle cell and thalassaemia (SCT) to all pregnant women. We also offer to screen the baby’s biological father if the mother is found to be a carrier of or have a sickle cell or thalassaemia condition.
Our 3 antenatal screening programmes have joined forces with the national Screening Quality Assurance Service (SQAS) team to hold 8 regional workshops during 2017.
One of the values we hold dear in PHE Screening is supporting individuals to make an informed choice about screening.